MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Apathy correlated with motor and non-symptoms in de-novo patients with Parkinson’s disease

S. Lee, S. Jo, J. Lee, S. Chung (Seoul, Republic of Korea)

Meeting: 2023 International Congress

Abstract Number: 467

Keywords: Apathy, Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: We aimed to investigate how the severity of apathy affects motor symptom and other non-motor symptoms in patients with de-novo Parkinson’s disease (PD).

Background: Apathy is a common non-motor symptom of PD that may associate with motor symptoms in PD patients. The severity of apathy is associated with decrease of treatment effect and impairs quality of life. However, most studies were conducted in advanced stage of PD, and the clinical implication of apathy in early PD is still lacking.

Method: In this retrospective study, we investigated de-novo PD patients at Asan Medical Center from March 2021 to December 2022. We analyzed baseline demographics, severity of motor symptom assessed by Unified Parkinson’s Disease Rating Scales (UPDRS) part III, apathy assessed by Apathy Evaluation Scale (AES), and quality of life assessed by The Parkinson’s Disease Questionnaire (PDQ-39). Additionally, we investigated non-motor symptoms other than apathy using Non-Motor Symptoms Scale (NMSS), which includes 8 subscores (cardiovascular, sleep and fatigue, mood, problem, hallucination, attention and memory, gastrointestinal symptoms, urinary symptoms, and miscellaneous).

Results: We enrolled 68 patients with de-novo PD, including 38 female (55.9%), with mean age of 64.7 ± 9.9 years. The mean severity of motor symptoms, assessed by UPDRS part III, was 22.4 ± 11.1 and mean AES was 44.8 ± 7.9. In the univariable linear regression analysis, the severity of motor symptoms was significantly associated with apathy (beta = 0.469, P < 0.001). Also, the severity of apathy was significantly associated with non-motor symptoms, assessed using NMSS, BDI, HADS, and PDQ-39. In the multivariable linear regression analysis, the severity of sleep symptoms was significantly associated with AES score (beta = 2.999, P = 0.008) among eight subgroup of NMSS.

Conclusion: In this study, we found that the severity of apathy is associated motor and non-motor symptoms in de-novo PD patients. Further researches are required to find the pathomechanism connecting apathy, sleep problem, and quality of life in de-novo PD patients.

To cite this abstract in AMA style:

S. Lee, S. Jo, J. Lee, S. Chung. Apathy correlated with motor and non-symptoms in de-novo patients with Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/apathy-correlated-with-motor-and-non-symptoms-in-de-novo-patients-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/apathy-correlated-with-motor-and-non-symptoms-in-de-novo-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley